{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-04T04:58:52.703950+00:00","company":{"ticker":"JUNS","cik":1679628,"company_name":"JUPITER NEUROSCIENCES, INC."},"pagination":{"limit":100,"returned":4,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"exchange_compliance_notice","fact_key":"504545a4a4d590ff34f45f34f73d7386e0984e15","cik":1679628,"ticker":"JUNS","company_name":"JUPITER NEUROSCIENCES, INC.","filed_at":"2026-02-27T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"market_value","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$35 million","notice_date":"2026-02-26","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5550(b)(2) for MVLS Requirement","reported_value":"below $35 million","rule_numbers":["5550(b)(2)"],"rules_cited_in_text":true},"claim":"JUPITER NEUROSCIENCES, INC. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).","evidence_excerpt":"February 26, 2026, Jupiter Neurosciences, Inc. (the “ Company ”) received two written notices (each, a “ Notice ”\nand together, the “ Notices ”) from the Listing Qualifications Department of Nasdaq Stock Market LLC (“ Nasdaq ”)\nnotifying the Company that (i) the listing of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”)\nwas not in compliance with the minimum bid price requirement (the “ Minimum Bid Price Requirement ”) as set forth under\nNasdaq Listing Rule 5550(a)(2) for continued listing of its Common Stock on The Nasdaq Capital Market, as the closing bid price","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-008344","anchor_url":"https://secwatch.observer/filing/0001493152-26-008344#claim-504545a4a4d590ff34f45f34f73d7386e0984e15","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1679628/000149315226008344/0001493152-26-008344-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"c0a7d8d9bc1eb5a5d2c672112bab1fc958801263","cik":1679628,"ticker":"JUNS","company_name":"JUPITER NEUROSCIENCES, INC.","filed_at":"2026-02-27T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2026-08-25","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$1.00","notice_date":"2026-02-26","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5550(a)(2) / Minimum Bid Price Requirement; Listing Rule 5810(c)(3)(A) for cure period","reported_value":"less than $1.00","rule_numbers":["5550(a)(2)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"JUPITER NEUROSCIENCES, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"February 26, 2026, Jupiter Neurosciences, Inc. (the “ Company ”) received two written notices (each, a “ Notice ”\nand together, the “ Notices ”) from the Listing Qualifications Department of Nasdaq Stock Market LLC (“ Nasdaq ”)\nnotifying the Company that (i) the listing of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”)\nwas not in compliance with the minimum bid price requirement (the “ Minimum Bid Price Requirement ”) as set forth under\nNasdaq Listing Rule 5550(a)(2) for continued listing of its Common Stock on The Nasdaq Capital Market, as the closing bid price","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-008344","anchor_url":"https://secwatch.observer/filing/0001493152-26-008344#claim-c0a7d8d9bc1eb5a5d2c672112bab1fc958801263","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1679628/000149315226008344/0001493152-26-008344-index.htm"},{"fact_type":"material_agreement","fact_key":"46ee673ef4a96ef17ac348085f37eb55ad55abc5","cik":1679628,"ticker":"JUNS","company_name":"JUPITER NEUROSCIENCES, INC.","filed_at":"2026-02-20T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Omnibus Amendment","agreement_type":"notes_offering","counterparty":"YA II PN, LTD","effective_date":"2026-02-20","item_codes_triggered":["1.01"],"value_text":null},"claim":"JUPITER NEUROSCIENCES, INC. amended Omnibus Amendment with YA II PN, LTD (effective 2026-02-20).","evidence_excerpt":"On February 20, 2026, the Company and Yorkville entered into an Omnibus Amendment (the “Amendment”) to revise Section 1(c) of the A&R Convertible Notes, the “Monthly Payments” provision.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-007624","anchor_url":"https://secwatch.observer/filing/0001493152-26-007624#claim-46ee673ef4a96ef17ac348085f37eb55ad55abc5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1679628/000149315226007624/0001493152-26-007624-index.htm"},{"fact_type":"debt_financing","fact_key":"40b99d4c848826322febe511654064dc4ed33d93","cik":1679628,"ticker":"JUNS","company_name":"JUPITER NEUROSCIENCES, INC.","filed_at":"2025-10-27T23:59:59+00:00","payload":{"counterparty":"YA II PN, LTD","effective_date":"2025-10-24","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":null,"item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"$4.0 million"},"claim":"JUPITER NEUROSCIENCES, INC. incurred convertible notes of $4.0 million with YA II PN, LTD.","evidence_excerpt":"The first Pre-Paid Advance in the amount of $3,720,000 was disbursed to the Company on October 27, 2025, in exchange for the Company’s issuance to Yorkville of a Convertible Note in the principal amount of $4.0 million, which was issued with an “original issue discount” (“OID”) of 7.0% (or $280,000) and is initially convertible into Common Stock at a fixed conversion price of $1.50 per share (subject to adjustment as provided in such Convertible Note) (the “First Convertible Note”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-019783","anchor_url":"https://secwatch.observer/filing/0001493152-25-019783#claim-40b99d4c848826322febe511654064dc4ed33d93","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1679628/000149315225019783/0001493152-25-019783-index.htm"}]}